Medomics Seeks to Raise up to $4M for Sequencing-Based Mitochondrial Disease Dx
December 02, 2009
Medomics Seeks to Raise up to $4M for Sequencing-Based Mitochondrial Disease Dx
By Ben Butkus
The company expects to receive a $1 million investment from an undisclosed corporate co-investor if it can raise $2 million to $3 million in add-on funding.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.